149 related articles for article (PubMed ID: 11804665)
1. Serum ceruloplasmin and ferroxidase activity are decreased in HFE C282Y homozygote male iron-overloaded patients.
Lainé F; Ropert M; Lan CL; Loréal O; Bellissant E; Jard C; Pouchard M; Le Treut A; Brissot P
J Hepatol; 2002 Jan; 36(1):60-5. PubMed ID: 11804665
[TBL] [Abstract][Full Text] [Related]
2. Genetic study of variation in normal mouse iron homeostasis reveals ceruloplasmin as an HFE-hemochromatosis modifier gene.
Gouya L; Muzeau F; Robreau AM; Letteron P; Couchi E; Lyoumi S; Deybach JC; Puy H; Fleming R; Demant P; Beaumont C; Grandchamp B
Gastroenterology; 2007 Feb; 132(2):679-86. PubMed ID: 17258727
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemistry of the Hfe protein in patients with hereditary hemochromatosis, iron deficiency anemia, and normal controls.
Byrnes V; Ryan E; O'Keane C; Crowe J
Blood Cells Mol Dis; 2000 Feb; 26(1):2-8. PubMed ID: 10772870
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide association study identifies TF as a significant modifier gene of iron metabolism in HFE hemochromatosis.
de Tayrac M; Roth MP; Jouanolle AM; Coppin H; le Gac G; Piperno A; Férec C; Pelucchi S; Scotet V; Bardou-Jacquet E; Ropert M; Bouvet R; Génin E; Mosser J; Deugnier Y
J Hepatol; 2015 Mar; 62(3):664-72. PubMed ID: 25457201
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic expression of HFE mutations: a French study of 1110 unrelated iron-overloaded patients and relatives.
Moirand R; Jouanolle AM; Brissot P; Le Gall JY; David V; Deugnier Y
Gastroenterology; 1999 Feb; 116(2):372-7. PubMed ID: 9922318
[TBL] [Abstract][Full Text] [Related]
6. Plasma copper, iron, ceruloplasmin and ferroxidase activity in schizophrenia.
Wolf TL; Kotun J; Meador-Woodruff JH
Schizophr Res; 2006 Sep; 86(1-3):167-71. PubMed ID: 16842975
[TBL] [Abstract][Full Text] [Related]
7. [Role of the hemochromatosis gene in prophyria cutanea tarda. Prospective study of 56 cases].
Skowron F; Bérard F; Grézard P; Wolf F; Morel Y; Perrot H
Ann Dermatol Venereol; 2001 May; 128(5):600-4. PubMed ID: 11427792
[TBL] [Abstract][Full Text] [Related]
8. Blunted increase in serum hepcidin as response to oral iron in HFE-hemochromatosis.
Sangwaiya A; Manglam V; Busbridge M; Thursz M; Arnold J
Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):721-4. PubMed ID: 21654321
[TBL] [Abstract][Full Text] [Related]
9. HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: The hemochromatosis and iron overload screening study.
Adams PC; Pankow JS; Barton JC; Acton RT; Leiendecker-Foster C; McLaren GD; Speechley M; Eckfeldt JH
Circ Cardiovasc Genet; 2009 Feb; 2(1):34-7. PubMed ID: 20031565
[TBL] [Abstract][Full Text] [Related]
10. Elevated MCP-1 serum levels are associated with the H63D mutation and not the C282Y mutation in hereditary hemochromatosis.
Lawless MW; White M; Mankan AK; O'Dwyer MJ; Norris S
Tissue Antigens; 2007 Oct; 70(4):294-300. PubMed ID: 17767550
[TBL] [Abstract][Full Text] [Related]
11. HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload.
Barton JC; Wiener HW; Acton RT; Go RC
Blood Cells Mol Dis; 2005; 34(1):38-47. PubMed ID: 15607698
[TBL] [Abstract][Full Text] [Related]
12. A genotypic study of 217 unrelated probands diagnosed as "genetic hemochromatosis" on "classical" phenotypic criteria.
Brissot P; Moirand R; Jouanolle AM; Guyader D; Le Gall JY; Deugnier Y; David V
J Hepatol; 1999 Apr; 30(4):588-93. PubMed ID: 10207799
[TBL] [Abstract][Full Text] [Related]
13. Genotypic/phenotypic correlations in genetic hemochromatosis: evolution of diagnostic criteria.
Adams PC; Chakrabarti S
Gastroenterology; 1998 Feb; 114(2):319-23. PubMed ID: 9453492
[TBL] [Abstract][Full Text] [Related]
14. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD
Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507
[TBL] [Abstract][Full Text] [Related]
15. Correlates of hepcidin and NTBI according to HFE status in patients referred to a liver centre.
Ryan E; Ryan JD; Russell J; Coughlan B; Tjalsma H; Swinkels DW; Stewart S; Crowe JP
Acta Haematol; 2015; 133(2):155-61. PubMed ID: 25277871
[TBL] [Abstract][Full Text] [Related]
16. Low serum transferrin levels in HFE C282Y homozygous subjects are associated with low CD8(+) T lymphocyte numbers.
Macedo MF; Cruz E; Lacerda R; Porto G; de Sousa M
Blood Cells Mol Dis; 2005; 35(3):319-25. PubMed ID: 16140024
[TBL] [Abstract][Full Text] [Related]
17. Decreased iron burden in overweight C282Y homozygous women: Putative role of increased hepcidin production.
Desgrippes R; Lainé F; Morcet J; Perrin M; Manet G; Jezequel C; Bardou-Jacquet E; Ropert M; Deugnier Y
Hepatology; 2013 May; 57(5):1784-92. PubMed ID: 23322654
[TBL] [Abstract][Full Text] [Related]
18. Serum transferrin saturation increase is associated with decrease of antibacterial activity of serum in patients with HFE-related genetic hemochromatosis.
Jolivet-Gougeon A; Loréal O; Ingels A; Danic B; Ropert M; Bardou-Jacquet E; Aqodad N; Aussant-Bertel F; Ferec C; Brissot P
Am J Gastroenterol; 2008 Oct; 103(10):2502-8. PubMed ID: 18684194
[TBL] [Abstract][Full Text] [Related]
19. HFE genotype in patients with hemochromatosis and other liver diseases.
Bacon BR; Olynyk JK; Brunt EM; Britton RS; Wolff RK
Ann Intern Med; 1999 Jun; 130(12):953-62. PubMed ID: 10383365
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of the hemochromatosis-associated Cys282Tyr HFE gene mutation in a healthy Norwegian population in the city of Oslo, and its phenotypic expression.
Distante S; Berg JP; Lande K; Haug E; Bell H
Scand J Gastroenterol; 1999 May; 34(5):529-34. PubMed ID: 10423072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
